Expert Articles
Clinical Trials
India has become one of the leading destinations for Clinical Trials as it offers the right combination of affordability, skilled professionals, and a supportive research environment. A large patient population, strong Clinical Research infrastructure, and improved regulatory standards allow Pharmaceutical companies to conduct clinical studies more efficiently. These advantages of choosing India for clinical trials
Clinical Trials
How CROs Accelerate Drug Development and Regulatory Approval
Contract Research Organizations (CROs) provide a wide range of services that support Pharmaceutical companies throughout the Drug development lifecycle. Their expertise ranges from early-stage Drug discovery and preclinical research, Clinical Trial management, Regulatory affairs, and operational support. They help streamline development activities, enhance productivity, and accelerate the path to Regulatory approval by offering specialised scientific,
Clinical Trials
India as an Early-Phase Clinical Trials Destination: The Case Global Sponsors Are Missing
India has long been recognised as a preferred destination for Phase III clinical trials. What is less widely understood is that it has quietly become an increasingly compelling destination for early-phase clinical trials—Phase I and II studies — and that the regulatory and operational environment behind this shift has matured substantially. The New Drugs and
Clinical Trials
Vaccine Clinical Trials in India: Vaccine Development Regulatory Pathway
Vaccine Clinical Trials are a critical component of vaccine development, ensuring that vaccines are safe, effective, and suitable for public use before widespread deployment. India has established a robust Clinical Research ecosystem supported by strong Regulatory oversight, experienced investigators, and extensive manufacturing capabilities. The country’s success in conducting large-scale Vaccine Trials, particularly during the COVID-19